LONDON — A study published in the journal Nature has elucidated the mechanism by which smoking increases the risk of lung cancer, resolving a longstanding question in oncology regarding the relationship between genetic mutations and tissue health.
Researchers found that cigarette smoke induces widespread mutations in lung cells. However, the study demonstrated that these genetic alterations alone are insufficient to cause cancer. Instead, chronic inflammation resulting from smoking creates a biological microenvironment that promotes the proliferation of these mutated cells.
The findings explain why healthy human tissue often carries driver mutations without developing tumors. The research indicates that while the genetic 'spark' is necessary, the inflammatory 'fuel' provided by smoking is what enables these damaged cells to progress into malignant growths.
Scientists involved in the study emphasize that this distinction highlights the importance of the tissue microenvironment in cancer development. The work suggests that targeting inflammatory pathways could be a significant avenue for future cancer prevention and treatment strategies, shifting the focus from mutational damage alone to the broader biological context of tumor initiation.
The study, conducted by an international team of researchers, provides a more nuanced understanding of carcinogenesis, indicating that the interaction between genetic damage and inflammatory response is critical in the progression from healthy tissue to tumor.
